How the mRNA technology behind COVID-19 vaccines could ‘turbo-charge’ cancer treatments
Cancer patients who received the mRNA-based jab after starting immunotherapy lived significantly longer than those who did not get the vaccine.
Cancer patients who received the mRNA-based jab after starting immunotherapy lived significantly longer than those who did not get the vaccine.
What's Your Reaction?
